Responses
Regular and young investigator award abstracts
Clinical trials completed
300 Final analysis of a prospective, randomized, double-blind, placebo-controlled phase IIb trial of tumor lysate, particle-loaded, dendritic cell vaccine in stage III/IV melanoma: 36-month analysis
Compose a Response to This Article
Other responses
No responses have been published for this article.
